Company Filing History:
Years Active: 2022
Title: The Innovations of Els Pattyn
Introduction
Els Pattyn is a notable inventor based in Huise, Belgium. He has made significant contributions to the field of immunology, particularly through his innovative work on polypeptides that inhibit CD40L. His research has implications for therapeutic and diagnostic applications, showcasing the potential of his inventions in the medical field.
Latest Patents
Els Pattyn holds a patent for "Polypeptides inhibiting CD40L." This invention relates to immunoglobulins that specifically bind to CD40L, focusing on polypeptides and nucleic acids encoding such polypeptides. The patent also covers methods for preparing these polypeptides and compositions, especially pharmaceutical compositions that include them for prophylactic, therapeutic, or diagnostic purposes. The immunoglobulins developed by Pattyn are designed to inhibit the activity of CD40L while ensuring safety for potential applications.
Career Highlights
Els Pattyn is associated with Ablynx N.V., a company known for its innovative approaches in biopharmaceuticals. His work at Ablynx has allowed him to explore and develop groundbreaking solutions in the field of immunology. His dedication to research and development has positioned him as a key figure in advancing therapeutic options for various medical conditions.
Collaborations
Els Pattyn collaborates with talented individuals such as Ariëlla Van De Sompel and Peter Meerts. These collaborations enhance the research environment and contribute to the successful development of innovative solutions in their field.
Conclusion
Els Pattyn's contributions to immunology through his patent on polypeptides inhibiting CD40L highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic and diagnostic applications, demonstrating the importance of innovation in medicine.